Dendritic cell (DC)-based vaccines continue to be considered an attractive tool for cancer immunotherapy. DCs require an additional signal from the environment or other immune cells to polarize the development of immune responses toward T helper 1 (Th1) or Th2 responses. DCs play a role in natural killer (NK) cell activation, and NK cells are also able to activate and induce the maturation of DCs. We investigated the types of NK cells that can induce the maturation and enhanced function of DCs and the conditions under which these interactions occur. DCs that were activated by resting NK cells in the presence of inflammatory cytokines exhibited increased expression of several costimulatory molecules and an enhanced ability to produce IL-12p70. NK cell-stimulated DCs potently induced Th1 polarization and exhibited the ability to generate tumor antigen-specific cytotoxic T lymphocyte responses. Our data demonstrate that functional DCs can be generated by coculturing immature DCs with freshly isolated resting NK cells in the presence of Toll-like receptor agonists and proinflammatory cytokines and that the resulting DCs effectively present antigens to induce tumor-specific T-cell responses, which suggests that these cells may be useful for cancer immunotherapy.
INTRODUCTION
Dendritic cells (DCs) are key antigen-presenting cells, capable of initiating primary T cell responses and linking innate immunity and adaptive immunity in antitumor immune responses. 1 To initiate a productive T-cell response, immature DCs must undergo a maturation and activation process, which results in the expression of high levels of major histocompatibility complex (MHC) and costimulatory molecules, allowing the DCs to present antigens and activate T cells.
1 DCs stimulate T cells through antigen-specific and costimulatory signals, both of which are required for the activation and expansion of pathogen-specific T cells.
1,2 In addition, DCs require an additional signal to polarize developing immune responses toward T helper 1 (Th1) or Th2 responses. 3, 4 Several factors or cytokines can directly induce the maturation of DCs toward type 1 or type 2 DC fates, resulting in the polarization of naive T cells to Th1 or Th2 cell fates, respectively. [3] [4] [5] [6] The presence of interferon (IFN)-c or IFN-c-producing cells, such as CD8 1 T cells or natural killer (NK) cells, at the final stages of DC maturation, leads to the development of a type 1-polarized DC subset, which produces increased levels of IL-12p70 after contact with naive Th cells and induces Th1-like differentiation in naive Th cells. 7, 8 NK cells are the major lymphocyte population of the innate immune response and function through the production of cytokines and lysis of virus-infected cells or tumor cells. 9 The activation of NK cells relies on a combination of interactions with cytokine receptors, adhesion molecules and activating receptors ligated via interactions with tumors, pathogen-infected cells or other immune cells. 10, 11 Interactions between NK cells and DCs result in activation of and cytokine production by both cell types, including NK cell proliferation, cytokine production and cytotoxicity and further DC maturation and activation. [12] [13] [14] [15] Recently, NK cells have also been shown to play immunoregulatory 'helper' roles, by activating DCs and enhancing their ability to produce pro-inflammatory cytokines, as well as to stimulate Th1 and cytotoxic T lymphocyte (CTL) responses of tumor-specific CD4 1 and CD8 1 T cells, respectively. 7, 16, 17 In our previous study, we proposed that potent DCs were generated by NK cell-mediated maturation in the presence of Toll-like receptor (TLR) 4 agonist, and vaccination with these DCs demonstrated strong efficacy in a mouse colon cancer model. 18 Although the above data suggest that NK cells and DCs can reciprocally activate each other during the immune response, which type of NK cells (freshly isolated resting cells or previously activated cells) are most effective in inducing the activation and maturation of DCs remains unknown. In addition, the optimal conditions for NK cell-mediated DC maturation require further investigation.
Therefore, we investigated the ability of different types of NK cells and different culture conditions to enhance the maturation and function of DCs. Our data demonstrate that functional DCs can be generated by coculturing immature DCs with freshly isolated resting NK cells in the presence of TLR agonist and pro-inflammatory cytokines. Importantly, DCs generated in this manner showed an enhanced capacity to induce T-cell responses.
MATERIALS AND METHODS

Generation of monocyte-derived immature DCs
All experiments were performed after obtaining informed consent from the subjects, according to a protocol approved by the Chonnam National University Hwasun Hospital Institutional Review Board. Monocytes were isolated from the peripheral blood of healthy donors using two-step density gradient centrifugation, followed by plastic adherence as previously described. 19 The adherent monocytes, which were more than 95% pure, were cultured for 6 days in 24-well plates (BD Biosciences-Labware, San Jose, CA, USA) at a density of 5310 5 cells per well in complete medium containing RPMI-1640 supplemented with 10% fetal bovine serum and 1% penicillinstreptomycin (all from Gibco-BRL, Grand Island, NY, USA) in the presence of 50 ng/ml GM-CSF (LG Biochemical, Daejeon, Korea) and 10 ng/ml IL-4 (R&D Systems, Minneapolis, MN, USA) to generate immature DCs (iDCs).
Preparation of activated NK cells CD56
1 NK cells were isolated from the lymphocyte fraction from the same donor using the magnetic activated cell sorting system (Miltenyi Biotec, Auburn, CA, USA). NK cells were used when .95% were CD56-positive. For preparation of activated NK cells, purified NK cells were cultured in complete medium for 48 h in the presence of IL-2 (50 U/ml) (R&D Systems), IL-2 and poly(I:C) (10 mg/ml) (SigmaAldrich, St Louis, MO, USA) or IL-2, poly(I:C) and IFN-a (10 000 U/ ml) (LG Life Science, Chonbuk, Korea). Before coculturing cells with DCs, activated NK cells were harvested and washed three times to remove all excess reagents. iDC and NK cell coculture conditions To assess the optimal conditions for DC and NK cell coculture, iDCs (2.0310 5 ) were either directly cocultured with NK cells (4.0310 5 ) or separated from NK cells by transwell membranes with 0.4-mm pore diameters in 24-well plates in the presence of IL-2 and/or poly(I:C). iDCs were placed in the lower chamber, and NK cells were placed in the upper chamber (Costar, Cambridge, MA, USA). After 48 h, the cells were harvested and analyzed for the expression of costimulatory molecules and the ability to produce IL-12.
NK cell-mediated DC maturation Based on the results of our preliminary experiments, iDCs and NK cells were cocultured at a ratio of 1 : 2. For DC maturation, iDCs were directly cocultured with either freshly isolated autologous resting NK cells or activated NK cells in 24-well plates. When indicated, IL-2, poly(I:C) and IFN-a were added to cocultures containing iDCs and resting NK cells to induce DC maturation. Alternatively, iDCs were matured with lipopolysaccharide (LPS) to compare the migration capacity of NK cell-matured DCs to that of DCs that were maturated with TLR ligand only.
To test the killing activity of NK cells, matured DCs were stained with nonyl acridine orange (NAO) on day 8, and the frequency of apoptotic cells was analyzed by flow cytometry. Briefly, DCs (53 10 5 cells) were stained with 0.5 mg/ml NAO (Molecular Probes; Invitrogen, Paisley, UK) in RPMI-1640 for 15 min at 37 uC in 5% CO 2 . The cells were then washed and immediately analyzed using a FACSAria cell sorter (Becton Dickinson, San Jose, CA, USA). A light scatter gate was used to exclude events with very low forward and side scatter from the NAO samples on the assumption that they were cell debris. Data were analyzed with WinMDI Version 2.9 software (Biology Software Net).
Phenotypic and cytokine analysis of DCs Fluorescence-activated cell sorting (FACS) analysis was performed using phycoerythrin-labeled monoclonal antibodies (mAbs) specific for human CD80, CD86 or CD38 or using fluorescein isothiocyanatelabeled mAbs specific for CD83 or CCR7 (all from BD Biosciences Pharmingen). Isotype matched controls were analyzed in parallel. Cell debris was eliminated from the analysis by forward and side scatter gating. Data were acquired on a FACSAria cell sorter (Becton Dickinson) and analyzed with FACSDiva (Becton Dickinson) and Win MDI Version 2.9 software (Biology Software Net).
To analyze cytokine production, we measured the levels of IFN-c and IL-12p70 in the culture supernatants using a BD OptEIA ELISA Set (BD Bioscience). The mature DCs were harvested on day 8, plated in 96-well flat-bottomed plates at a density of 2310 4 4 matured DCs that were pre-incubated with 1 ng/ml of Staphylococcus aureus enterotoxin B in 96-well flat-bottomed plates. On day 5, 10 U/ml rhIL-2 was added to each well. On day 10, the expanded CD4
1 Th cells were washed, counted, plated in 96-well plates, and stimulated with CD3 and CD28 mAbs (Dynabeads CD3/CD28 T Cell Expander; Invitrogen). The supernatants from restimulated CD4 1 Th cells were collected after 24 h, and the concentrations of the Th1 cytokine IFN-c and the Th2 cytokine IL-13 were measured using a BD OptEIA ELISA Set (BD Bioscience).
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Migration assays
The ability of DCs to undergo chemotaxis toward the chemokines CCL19 and CCL21 was measured by migration through a polycarbonate filter of 5 mm pore size in 24-well transwell chambers (Corning Costar), as described previously. 8 Briefly, the lower chamber was filled with 600 ml of medium containing 250 ng/ml of CCL19 and CCL21 (BD Biosciences) or medium alone as a control. DCs (1310 5 ) were added to the upper chamber in 100-ml medium. Migration chambers were incubated for 3 h at 37 uC. A 500-ml aliquot of the cells that migrated to the bottom chamber was assessed by flow cytometry using a FACSAria cell sorter (BD Biosciences). Events were acquired for a fixed period of 60 s using CellQuest software (BD Biosciences). The results are expressed as the number of migrated cells, which was defined as follows: the number of cells that migrated into the lower chamber containing chemokines2the number of cells that migrated into the lower chamber containing medium alone.
In vitro tumor-specific CTL expansion CTLs were generated as previously described. 20 Autologous CD3 1 T cells obtained from the lymphocyte fraction from the same donor were isolated using the magnetic activated cell sorting system (Miltenyi Biotec).
CD3
1 T cells ( 1310 6 ) were stimulated with irradiated DCs (2310 5 cells) that had previously been loaded with ultraviolet B-irradiated ARH-77 tumor cells. On day 3, 10 ng/ml rhIL-2 and 5 ng/ml IL-7 (both from R&D Systems) were added. The CTLs were restimulated with the same DCs on day 10. After 20 days, the CTLs were harvested, and 51 Cr release assays were performed to measure the cytotoxic activities of the CTLs. 
Statistical analysis
All statistical analyses were performed with SPSS 13.0 for Windows. The Mann-Whitney U test was performed to analyze the statistical significance of non-parametric differences between the groups. P,0.05 was considered statistically significant.
RESULTS
Direct cell-to-cell contact is required for NK cell-mediated DC maturation To determine whether NK cell-mediated DC maturation requires direct cell-to-cell contact or involves soluble factors, we compared the maturation status of DCs following coculture with NK cells with or without separation by a transwell membrane in the presence of IL-2 and/or poly(I:C). On day 8 of the coculture, DCs that were cocultured in direct contact with NK cells displayed a more activated phenotype than DCs that were separated from NK cells by a transwell membrane (Figure 1 ). Immature DCs expressed moderate levels of CD86 and very low levels of CD83. The activation of NK cells with IL-2 alone induced upregulation of CD86 and CD83 expression; however, when NK cells were stimulated with a combination of IL-2 and poly(I:C), the cocultured DCs showed enhanced expression of CD86 and CD83. As we expected, the expression levels of these molecules were significantly higher in DCs cocultured in direct contact with NK cells than in DCs separated from NK cells by a transwell membrane (Figure 1a) . Furthermore, direct coculture of NK cells with immature DCs in the presence of either IL-2 alone or IL-2 and poly(I:C) significantly increased production of IL-12p40 (Figure 1b) and IL-12p70 (Figure 1c) , both during maturation and after subsequent CD40L stimulation (*P,0.05). Thus, NK cell-mediated DC maturation required direct cell-to-cell contact, and the effective induction of DC maturation in the bystander model suggests a key role for NK cell-produced soluble factors in this process.
NK cells induce type 1-polarized DCs with the capacity to produce IL-12p70 To determine whether resting or activated NK cells could enhance DC maturation, we analyzed the phenotype of DCs that were cocultured with either freshly isolated resting NK cells in the presence of IL-2, poly(I:C) and IFN-a or NK cells that had been activated with these stimuli before coculturing. On day 6 of culture, iDCs expressed intermediate levels of CD86 and low levels of CD83, CCR7 and CD38. Coculturing iDCs with resting NK cells in the presence of various stimuli induced upregulation of CD86, CD83 and CCR7 on DCs more efficiently than coculturing iDCs with activated NK cells. In addition, DCs cocultured with resting NK cells in the presence of stimuli also expressed high levels of CD38, a recently identified DC activation marker that orchestrates migration, survival and induction of Th1 immune response by DCs. 8, 22 The expression of these molecules in this study was dependent not only on the type of NK cells used but also on the stimulation conditions (IL-21poly(I:C)1IFN-a.IL21poly(I:C).IL-2) (Figure 2a) .
To determine whether coculturing iDCs with resting NK cells in the presence of different stimuli could enhance DC maturation, we measured the production of IL-12p70 after subsequent stimulation of the cocultured DCs with CD40L-transfected J558 cells. In accord with the surface phenotype of DCs cocultured with resting NK cells in the presence of stimuli, we found that these DCs demonstrated enhanced IL-12p70 production when compared to DCs cocultured with activated NK cells or control iDCs ( Figure 2b ) (P,0.05). In addition, the production of IL-12p70 was also dependent on the stimuli present during the coculture period (IL-21poly(I:C)1IFN-a.IL-21 poly(I:C).IL-2).
Previous studies have shown that soluble factors affect DC maturation, including IFN-c and tumor-necrosis factor (TNF)-a, are produced during DC-NK cell interactions. 17 We found that IFN-c production was significantly higher in NK cells that were activated with both DCs and cytokines than in those cells activated with cytokines alone or DCs alone (P,0.05) (Figure 2c ). The same pattern was observed for TNF-a (data not shown). Interestingly, the production of IFN-c and TNF-a was also dependent on the stimuli present during the coculture period (IL-21poly(I:C)1IFN-a.IL-21poly(I:C).IL-2).
NK cells induce apoptosis of un-matured DCs to further enhance DC maturation Theoretically, NK cell activation results in the killing of un-matured DCs. [13] [14] [15] We therefore evaluated the capacity of NK cells to induce
apoptosis in un-matured DCs. Because decreased levels of cardiolipin in the mitochondrial inner membrane are indicative of apoptosis, 23 we stained harvested DCs with NAO to detect the loss of mitochondrial cardiolipin, and thus mitochondrial damage, by flow cytometry. NK cell activation resulted in a number of apoptotic cells under all culture conditions. A slight increase in apoptotic DCs was observed when DCs were cocultured with NK cells in the presence of poly(I:C) with or without IFN-a; however, no significant difference in apoptosis was observed between DCs cocultured with activated or resting NK cells in the absence of stimuli (Figure 3) . These results suggest that coculturing DCs with NK cells may result in the killing of un-matured DCs, allowing for the selection of mature DCs.
Resting NK cell-stimulated DCs strongly enhance T-cell proliferation and drive Th1 polarization of naive T cells To evaluate the proliferation of T cells, allogeneic CD3
1 T cells obtained from healthy volunteers were stimulated with various types of DCs, and allogeneic mixed lymphocyte reactions were performed in three independent experiments using [ To assess the ability of DCs to induce Th1 polarization, we compared the levels of Th1 cytokine (IFN-c) and Th2 cytokine (IL-13) production in naive T cells primed by DCs cocultured with NK cells under different conditions. DCs cocultured with resting NK cells in the presence of poly(I:C) and IFN-a induced strong Th1 responses in naive T cells, resulting in the production of high levels of IFN-c and low levels of IL-13 after restimulation with CD3/CD28 mAbs.
Resting NK cells enhance the migration of DCs toward CCL19 and CCL21 As migration is a key element of DC biology, we also investigated whether coculture with NK cells influenced the migratory response of DCs in vitro. Coculturing DCs with NK cells in the presence of TLR agonists and IFN-a upregulated CCR7 and CD38 on DCs, resulting in DC homing to lymph nodes. 8, 22 Recent reports have suggested that CCR7 expression does not always guarantee CCL19/CCL21 responsiveness. 24 In addition, the upregulation of CD38 has been shown to regulate DC migration in vitro. 8 Resting NK cell-stimulated DCs enhanced the expression of CCR7 and CD38, compared to (c) To assess IL-12p70 production, all DCs were further stimulated with CD40L-transfected J558 cells. IL-12p70 levels were significantly higher in supernatants from cells cocultured in direct contact (*P,0.05).
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activated NK cell-stimulated DCs; we thus examined the migratory capacity of these DCs. LPS-stimulated DCs were assessed in parallel as a control. As we expected, the capacity of DCs cocultured with resting NK cells to migrate towards CCL19 and CCL21 was greater than those of either LPS-stimulated DCs or DCs cocultured with activated NK cells (P,0.05) ( Figure 5 ).
Resting NK cell-polarized DCs have an enhanced ability to induce potent tumor-specific CTL responses
To determine the ability of NK cell-stimulated DCs to induce potent tumor-specific CTL responses, we performed a standard 4-h [ 51 Cr] release assay in three independent experiments. As shown in Figure 6 , the CTLs generated by DCs that were stimulated with resting NK cells in the presence of stimuli, but not those simulated with activated NK cells, exhibited highly specific killing activity against ARH77 cells. While the cytotoxic activity of CTLs induced by activated NK cellstimulated DCs was inhibited by anti-MHC class I antibody only at an E/T ratio of 20 : 1, the cytolytic activity of CTLs induced by resting NK cell-stimulated DCs against ARH77 cells was markedly inhibited at E/ T ratios of both 20 : 1 and 10 : 1. Thus, experiments using an MHC class I blocking antibody verified that CTL responses induced by resting NK cell-stimulated DCs were HLA class I-restricted. None of the DCs generated CTL responses against K562 cells (data not shown).
DISCUSSION
This study demonstrates that freshly isolated resting NK cells obtained from peripheral blood are capable of stimulating the maturation of DCs in the presence of IL-2, poly(I:C) and IFN-a. In the presence of such NK cells, immature DCs matured to form phenotypically and functionally mature DCs. Importantly, these DCs expressed high levels of CD38, a molecule typically associated with DC migration, survival and induction of Th1 immune responses. These DCs efficiently produced IL-12p70 and stimulated T-cell proliferation and Th1 polarization of naive CD4 1 T cells. Resting NK cell-induced DCs were also potent antigen-presenting cells because they demonstrated an enhanced ability to induce tumor-specific CTL responses. In addition, we defined two culture conditions required for an efficient NK cell-DC interaction: (i) direct cell-to-cell contact; and (ii) coculture of DCs with freshly isolated resting NK cells in the presence of stimuli, which resulted in more efficient DC maturation than did coculture with preactivated NK cells. Several cytokines, such as type I IFN, IL-12, TNF-a and IL-15, are potent inducers of NK cell activation, and all of them are secreted by human DCs, following culture with maturation stimuli. 25 Reciprocally, DCs can be activated by interaction with NK cells in the presence of several cytokines that can be secreted by activated NK cells. [12] [13] [14] [15] In accordance with recent reports, [13] [14] [15] our results show that although coculturing DCs and NK cells separated by a transwell insert in the presence of stimuli can induce the maturation of DCs, direct cell-to-cell contact is necessary for NK cell-mediated DC maturation. In addition, NK cells enhanced the maturation of iDCs in both the presence and the absence of TLR3 agonist (poly(I:C)) in direct contact conditions; however, culturing DCs in direct contact with NK cells in the presence of a TLR3 agonist resulted in increased expression of CD86 and CD83 and enhanced cytokine production.
In our study, the crucial factor for the successful generation of potent DCs via NK cell-mediated maturation was the use of resting NK cells in the presence of stimuli rather than activated NK cells. The two-signal requirement for the induction of NK ''helper'' activity was met by using freshly isolated NK cells in the presence of an additional costimulatory signal. 7, 16 The presence of IFN-c (which can be induced by TLR ligands) during DC maturation overcomes maturation-associated DC 'exhaustion', yielding stable type 1-polarized DCs that produce higher levels of IL-12p70 and exhibit a dramatically enhanced capacity to induce Th1 responses. 26 It has been reported that IFN-c is produced by NK cells after 17 h of stimulation with poly(I:C), and it peaks at 48 h. 27 In our study, the level of IFN-c production in resting NK cells after 48 h of stimulation in the presence of TLR agonists and cytokines was higher than that observed in either activated NK cells or resting NK cells in the absence of costimulatory signals. This finding may explain why resting NK cells in the presence of stimuli induced the maturation and function of DCs more efficiently than activated NK cells. Furthermore, the cross-talk between immature DCs and resting NK cells leads to cell activation only in the presence of additional stimuli. [13] [14] [15] A second reason for the enhanced ability of resting NK cells in the presence of stimuli to induce DC maturation may be the killing activity of activated NK cells. Although we did not detect any significant killing of DCs by resting NK cells or activated NK cells, it is possible that depending on the cytolytic activity of activated NK cells, the DC/NK cell ratio or the presence of particular NK cell subsets, NK cells will mainly kill or inactivate DCs, resulting in suppression of the immune response. 7 The key to the initiation of immune responses to pathogens is the recognition of pathogen associated ligands that are not normally expressed by host cells. This recognition is mediated by members of the TLR family, several of which are expressed by immature DCs 28 and NK cells. 27, 29 The maturation of DCs (which is considered crucial for functions, including survival, migration, secretion of cytokines and chemokines and expression of costimulatory molecules) is influenced by signaling through TLRs. 28 Human NK cells express functional TLR3, enabling them to respond to viral infection through enhanced cytokine production and cytotoxic activity. 29 To initiate DC activation and maturation, NK cells must be activated, and our data show that NK cells produced higher levels of IFN-c and TNF-a upon stimulation by exogenous cytokines. The production of cytokines by NK cells was dramatically enhanced when NK cells were cocultured with DCs in the presence of exogenous cytokines. These results suggest that NK cells efficiently enhance DC maturation in coculture systems.
To investigate the mechanism underlying the DC maturation induced by resting NK cells in the presence of stimuli, we used IL-2 as the first activator of NK cells. IL-2-activated human NK cells can trigger maturation of immature DCs by upregulating the costimulatory molecule CD86, resulting in enhancement of the T-cell stimulatory capacity of DCs. 15 In accord with previous reports, our results showed that only resting NK cells efficiently induced the maturation of DCs, as indicated by the upregulation of maturation-related markers and the increased production of IL-12. In contrast, IL-2-activated NK cells induced DC maturation less efficiently. Therefore, our findings suggest that efficient interactions between NK cells and DCs required conditions in which both cells were activated together.
Previous studies have shown that IFN-a has important functions in DC maturation, NK cell activation, Th1 polarization and CTL priming in vitro. 30, 31 The presence of IFN-a during DC maturation results in the development of type 1-polarized effector DCs with an enhanced ability to produce IL-12 and a strong Th1-inducing capacity. 3 Therefore, by providing a 'signal 3', the addition of exogenous IFN-a is the DC-dependent component of the initial polarization of naive Th cells to preferentially produce Th1 cytokines. Our data demonstrate that potent DCs can be generated by coculture with resting NK cells in the presence of TLR3 agonist, IL-2 and IFN-a. Although IFN-a can be secreted by human DCs upon maturation stimulus, the addition of exogenous IFN-a increases the production of IL-12p70 and may induce Th1 immune responses in our system. Coculturing DCs with resting NK cells in combination with these stimuli increased the expression of the surface molecule (CD86, IFN-a, which is secreted by virus-infected cells, can induce both DC maturation and NK cell activation. In the presence of an inflammatory stimulus (TLR ligands, type I IFN or bacterial products), DC/NK cross-talk leads to not only NK cell activation but also DC maturation.
14,15 Therefore, we propose the following model to explain the ability of DC-NK cell coculture in the presence of IL-2, poly(I:C) and IFN-a to induce DC maturation. After recognizing the microbial TLR ligand poly(I:C), NK cells become activated. At the same time, immature DCs are activated by poly(I:C) to release abundant IL-12. The secreted IL-12 and the additional IL-2 further induce NK cell activation. Stimulated NK cells produce increased levels of IFN-c to promote further maturation of DCs, resulting in increased production of IL-12p70 and acquisition of the capacity to induce Th1 immune responses. In addition, IL-12-stimulated NK cells become highly susceptible to other stimuli. This process forms a positive feedback loop between TLR-induced production of IL-12 and IL-12-mediated enhanced TLR ligand responsiveness in NK cells. Furthermore, NK cells exposed to IL-12 are further activated and can kill immature DCs, thus favoring the survival of mature DCs. In addition, IFN-a provides a 'signal 3' that can enhance both the activation of NK cells and the maturation of DCs, thus further promoting cross-talk between DCs and NK cells.
DCs induced by NK cells and NK cell-related products are powerful inducers of tumor-specific immune responses. 18, 33 These observations, which have been made both in vitro and in mice, suggest a potential method to improve the efficacy of DC immunotherapy by using NK-stimulated DCs. Examination of allogenic T-cell responses and tumor-specific T-cell cytotoxicity showed that resting NK cellstimulated DCs induced more effective and functional T-cell responses than activated NK cell-stimulated DCs. Our results suggest that NK cell-stimulated DCs could be potentially useful for immunotherapy against cancer.
In conclusion, the results of our study suggest that potent DCs can be generated by resting NK cells in the presence of TLR agonist and pro-inflammatory cytokines, and these DCs can be used to induce tumor-specific CTLs that exert an effective anti-tumor immune response for cancer immunotherapy. 
